The scope of the report is limited to revenue generated from sales of shunts used in treatment of hydrocephalus. These products include ventriculo-peritoneal (VP) shunts, ventriculo-atrial (VA) shunts, ventriculo-pleural (VPL) shunts, and lumbo-peritoneal (LP) shunts. However, the report does not include revenue generated from consultation fees, doctor fees, or post-sales services of shunts. Drivers, restraints, and opportunities in the market are provided to understand the market dynamics.b

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: HYDROCEPHALUS SHUNT MARKET, BY TYPE 

CHAPTER 5: HYDROCEPHALUS SHUNT MARKET, BY AGE GROUP 

CHAPTER 6: HYDROCEPHALUS SHUNTS MARKET, BY REGION 

CHAPTER 7: COMPANY PROFILES